Logo image of ADNT

ADIENT PLC (ADNT) Stock Fundamental Analysis

USA - NYSE:ADNT - IE00BD845X29 - Common Stock

24.59 USD
-0.63 (-2.5%)
Last: 9/19/2025, 8:04:00 PM
24.591 USD
0 (0%)
After Hours: 9/19/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, ADNT scores 4 out of 10 in our fundamental rating. ADNT was compared to 81 industry peers in the Automobile Components industry. ADNT may be in some trouble as it scores bad on both profitability and health. ADNT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ADNT was profitable.
ADNT had a positive operating cash flow in the past year.
In multiple years ADNT reported negative net income over the last 5 years.
In the past 5 years ADNT always reported a positive cash flow from operatings.
ADNT Yearly Net Income VS EBIT VS OCF VS FCFADNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

ADNT's Return On Assets of -2.49% is on the low side compared to the rest of the industry. ADNT is outperformed by 77.78% of its industry peers.
ADNT has a Return On Equity of -12.32%. This is in the lower half of the industry: ADNT underperforms 77.78% of its industry peers.
With a Return On Invested Capital value of 6.57%, ADNT is not doing good in the industry: 69.14% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for ADNT is below the industry average of 8.51%.
The last Return On Invested Capital (6.57%) for ADNT is above the 3 year average (5.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.49%
ROE -12.32%
ROIC 6.57%
ROA(3y)0.35%
ROA(5y)1.2%
ROE(3y)1.42%
ROE(5y)1.16%
ROIC(3y)5.11%
ROIC(5y)4.23%
ADNT Yearly ROA, ROE, ROICADNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

ADNT's Profit Margin has declined in the last couple of years.
The Operating Margin of ADNT (3.14%) is worse than 75.31% of its industry peers.
In the last couple of years the Operating Margin of ADNT has grown nicely.
The Gross Margin of ADNT (6.75%) is worse than 91.36% of its industry peers.
In the last couple of years the Gross Margin of ADNT has grown nicely.
Industry RankSector Rank
OM 3.14%
PM (TTM) N/A
GM 6.75%
OM growth 3Y-7.97%
OM growth 5Y33.2%
PM growth 3Y-75.27%
PM growth 5YN/A
GM growth 3Y-5.89%
GM growth 5Y5.44%
ADNT Yearly Profit, Operating, Gross MarginsADNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ADNT is still creating some value.
The number of shares outstanding for ADNT has been reduced compared to 1 year ago.
ADNT has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ADNT has an improved debt to assets ratio.
ADNT Yearly Shares OutstandingADNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ADNT Yearly Total Debt VS Total AssetsADNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

ADNT has an Altman-Z score of 1.84. This is not the best score and indicates that ADNT is in the grey zone with still only limited risk for bankruptcy at the moment.
ADNT has a worse Altman-Z score (1.84) than 76.54% of its industry peers.
ADNT has a debt to FCF ratio of 9.17. This is a negative value and a sign of low solvency as ADNT would need 9.17 years to pay back of all of its debts.
ADNT has a Debt to FCF ratio of 9.17. This is in the lower half of the industry: ADNT underperforms 71.60% of its industry peers.
ADNT has a Debt/Equity ratio of 1.34. This is a high value indicating a heavy dependency on external financing.
ADNT has a worse Debt to Equity ratio (1.34) than 86.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.34
Debt/FCF 9.17
Altman-Z 1.84
ROIC/WACC1.16
WACC5.67%
ADNT Yearly LT Debt VS Equity VS FCFADNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

ADNT has a Current Ratio of 1.12. This is a normal value and indicates that ADNT is financially healthy and should not expect problems in meeting its short term obligations.
ADNT's Current ratio of 1.12 is on the low side compared to the rest of the industry. ADNT is outperformed by 91.36% of its industry peers.
ADNT has a Quick Ratio of 1.12. This is a bad value and indicates that ADNT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ADNT (0.92) is worse than 82.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.92
ADNT Yearly Current Assets VS Current LiabilitesADNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

ADNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.40%, which is quite impressive.
Measured over the past 5 years, ADNT shows a small growth in Earnings Per Share. The EPS has been growing by 2.56% on average per year.
ADNT shows a decrease in Revenue. In the last year, the revenue decreased by -3.00%.
ADNT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.33% yearly.
EPS 1Y (TTM)24.4%
EPS 3Y-3.98%
EPS 5Y2.56%
EPS Q2Q%40.63%
Revenue 1Y (TTM)-3%
Revenue growth 3Y2.4%
Revenue growth 5Y-2.33%
Sales Q2Q%0.67%

3.2 Future

Based on estimates for the next years, ADNT will show a very strong growth in Earnings Per Share. The EPS will grow by 32.40% on average per year.
Based on estimates for the next years, ADNT will show a small growth in Revenue. The Revenue will grow by 0.64% on average per year.
EPS Next Y3.73%
EPS Next 2Y12.66%
EPS Next 3Y26.17%
EPS Next 5Y32.4%
Revenue Next Year-1.25%
Revenue Next 2Y-1.12%
Revenue Next 3Y0.31%
Revenue Next 5Y0.64%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ADNT Yearly Revenue VS EstimatesADNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
ADNT Yearly EPS VS EstimatesADNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.77, which indicates a very decent valuation of ADNT.
70.37% of the companies in the same industry are more expensive than ADNT, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ADNT to the average of the S&P500 Index (27.38), we can say ADNT is valued rather cheaply.
ADNT is valuated reasonably with a Price/Forward Earnings ratio of 10.47.
ADNT's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of ADNT to the average of the S&P500 Index (22.86), we can say ADNT is valued rather cheaply.
Industry RankSector Rank
PE 11.77
Fwd PE 10.47
ADNT Price Earnings VS Forward Price EarningsADNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ADNT is valued a bit cheaper than 77.78% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ADNT is valued cheaply inside the industry as 95.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.65
EV/EBITDA 4.53
ADNT Per share dataADNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ADNT does not grow enough to justify the current Price/Earnings ratio.
ADNT's earnings are expected to grow with 26.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.16
PEG (5Y)4.59
EPS Next 2Y12.66%
EPS Next 3Y26.17%

0

5. Dividend

5.1 Amount

ADNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ADIENT PLC

NYSE:ADNT (9/19/2025, 8:04:00 PM)

After market: 24.591 0 (0%)

24.59

-0.63 (-2.5%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-06 2025-11-06/amc
Inst Owners99.49%
Inst Owner Change2.7%
Ins Owners0.95%
Ins Owner Change-0.49%
Market Cap2.00B
Analysts56.67
Price Target26.99 (9.76%)
Short Float %9.13%
Short Ratio6.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)47.22%
Min EPS beat(2)-6.89%
Max EPS beat(2)101.33%
EPS beat(4)3
Avg EPS beat(4)40.42%
Min EPS beat(4)-6.89%
Max EPS beat(4)101.33%
EPS beat(8)4
Avg EPS beat(8)10.94%
EPS beat(12)6
Avg EPS beat(12)13.41%
EPS beat(16)8
Avg EPS beat(16)15.54%
Revenue beat(2)2
Avg Revenue beat(2)1.85%
Min Revenue beat(2)0.92%
Max Revenue beat(2)2.79%
Revenue beat(4)3
Avg Revenue beat(4)1.3%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)2.79%
Revenue beat(8)3
Avg Revenue beat(8)-1.05%
Revenue beat(12)6
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.49%
PT rev (1m)10.97%
PT rev (3m)60.37%
EPS NQ rev (1m)2.28%
EPS NQ rev (3m)18.91%
EPS NY rev (1m)0%
EPS NY rev (3m)7.4%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)5.39%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)2.78%
Valuation
Industry RankSector Rank
PE 11.77
Fwd PE 10.47
P/S 0.14
P/FCF 7.65
P/OCF 4
P/B 1.12
P/tB N/A
EV/EBITDA 4.53
EPS(TTM)2.09
EY8.5%
EPS(NY)2.35
Fwd EY9.55%
FCF(TTM)3.21
FCFY13.06%
OCF(TTM)6.14
OCFY24.98%
SpS177.34
BVpS21.97
TBVpS-4.28
PEG (NY)3.16
PEG (5Y)4.59
Profitability
Industry RankSector Rank
ROA -2.49%
ROE -12.32%
ROCE 8.65%
ROIC 6.57%
ROICexc 7.86%
ROICexgc 15.32%
OM 3.14%
PM (TTM) N/A
GM 6.75%
FCFM 1.81%
ROA(3y)0.35%
ROA(5y)1.2%
ROE(3y)1.42%
ROE(5y)1.16%
ROIC(3y)5.11%
ROIC(5y)4.23%
ROICexc(3y)6.22%
ROICexc(5y)5.21%
ROICexgc(3y)13.54%
ROICexgc(5y)10.98%
ROCE(3y)6.73%
ROCE(5y)5.58%
ROICexcg growth 3Y4.55%
ROICexcg growth 5Y38.95%
ROICexc growth 3Y0.66%
ROICexc growth 5Y34.59%
OM growth 3Y-7.97%
OM growth 5Y33.2%
PM growth 3Y-75.27%
PM growth 5YN/A
GM growth 3Y-5.89%
GM growth 5Y5.44%
F-Score5
Asset Turnover1.63
Health
Industry RankSector Rank
Debt/Equity 1.34
Debt/FCF 9.17
Debt/EBITDA 3.06
Cap/Depr 73.01%
Cap/Sales 1.65%
Interest Coverage 250
Cash Conversion 64.06%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.92
Altman-Z 1.84
F-Score5
WACC5.67%
ROIC/WACC1.16
Cap/Depr(3y)73.03%
Cap/Depr(5y)79.22%
Cap/Sales(3y)1.69%
Cap/Sales(5y)1.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.4%
EPS 3Y-3.98%
EPS 5Y2.56%
EPS Q2Q%40.63%
EPS Next Y3.73%
EPS Next 2Y12.66%
EPS Next 3Y26.17%
EPS Next 5Y32.4%
Revenue 1Y (TTM)-3%
Revenue growth 3Y2.4%
Revenue growth 5Y-2.33%
Sales Q2Q%0.67%
Revenue Next Year-1.25%
Revenue Next 2Y-1.12%
Revenue Next 3Y0.31%
Revenue Next 5Y0.64%
EBIT growth 1Y5.35%
EBIT growth 3Y-5.76%
EBIT growth 5Y30.09%
EBIT Next Year65.98%
EBIT Next 3Y23.28%
EBIT Next 5Y25.86%
FCF growth 1Y-30.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.06%
OCF growth 3Y30.56%
OCF growth 5Y12.01%